CTSI Updates: Announcement
Seeking a Co-Director for the Institutional Career Development (KL2)
and Workforce Development Programs

The BU CTSI’s KL2 Program and Workforce Development programs aim to build a system that provides continuous comprehensive mentoring and career development support for scholars from postdoctoral training through early faculty years and to anticipate the skills that scholars will need for future success in research. If you are interested in learning more, go here
Reminder
TL1 Predoctoral Fellowships
in Regenerative Medicine
Application Deadline: Nov. 5, 2021.

The BU CTSI will support 2 predoctoral fellows as part the CTSI training program in regenerative medicine. We are committed to increasing the diversity of the research workforce and strongly encourages applications from underrepresented, racial, and ethnic groups (UREGs). Learn More
Career Development Award Writing Workshop Series - Spring 2022
Application Deadline: Nov. 19, 2021

Are you planning to submit a Career Development Award? Have you assembled mentors and developed a Specific Aims page, but want to ensure that you submit the most competitive application possible? Learn More
Program for Early Research Career Development - Spring 2022
Application Deadline: Dec. 10, 2021

The Program for Early Research Career Development will provide a roadmap and targeted guidance for senior post-doctoral fellows and early career faculty (both MD and PhD) committed to launching an independent research career. Learn More

Annual CTSI Regional Shared Mentoring Symposium - Virtual Event
Dec. 10, 2021, 8:30 am - 12:30 pm.
Register before Nov. 10, 2021

This symposium provides networking, panel discussions and one-to-one mentoring
with senior faculty from local clinical and translational science institutions. Learn More
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.

The Voucher Program supports the short-term needs of research investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for expert consultation services. Learn More
Funding & Fellowship Opportunities
Translational Science Interagency Fellowship
Apply before Dec. 15, 2021

The common goal of NCATS and the FDA is to bring safe and effective drugs, regimens, and devices from the bench to the bedside. To that end, fellows will be trained in preclinical translational science, technology development, and regulatory research and review. Learn More
August M. Watanabe Prize in
Translational Research
Apply before Jan. 21, 2022

The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science. The winner will receive $100,000 and will spend Sep. 14-16, 2022 in Indianapolis. Learn More
News Highlights
NIH, FDA, and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases

A standardized therapeutic development model that includes a common gene delivery technology (a vector) could allow for a more efficient approach to specific gene therapies, saving time and cost. Read More
National EHR Data Resource Reveals COVID-19’s Stark Mortality Risk in People with COPD

COPD is a chronic inflammatory lung disease most commonly caused by emphysema and chronic bronchitis. It’s the most common chronic lung disease in the United States and disproportionately impacts older adults.

NIH to Study Long-Term Effects
of COVID-19 in Pregnancy

The National Institutes of Health will support a four-year follow-up study on the potential long-term effects of COVID-19 on women infected with SARS-CoV-2 during pregnancy.
Upcoming Event
Improving Health for All Through Translational Science
Dec. 7, 2021, 12:30 - 5 pm

NCATS is hosting a virtual event to commemorate the Center's 10-year anniversary, usher in the next decade of bold solutions and highlight innovative and team-science approaches that are speeding health solutions. Featured topics will spotlight the transformational power of data, novel technologies for de-risking a drug’s journey along the preclinical pathway, crosscutting solutions for many diseases and high-impact innovations in clinical research. Speakers will provide perspective on remaining roadblocks and new opportunities through conversations and lightning-round talks. Learn More
The Funding Acknowledgement
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.